Supraventricular tachycardia (SVT) often goes undiagnosed due to subtle or intermittent symptoms. Learn why it’s missed and ...

Chloe Dygert revealed that she recently underwent a procedure to treat heart arrhythmia. The U.S. Olympic medalist confirmed doctors carried out a cardiac ablation to treat supraventricular ...

Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.

FDA approval for RAPIBLYK® (landiolol) for use in pediatric patients with SVT provides first therapeutic option for these ...

Untreated or unmanaged, SVT can lead to other possibly fatal heart abnormalities. Patients are advised to practice a cardiac-friendly diet and lifestyle (low sodium, little to no caffeine or alcohol, ...

PHILADELPHIA (WPVI) -- The human heart beats about a hundred thousand times a day. When the beat isn't regular, it's something called an arrhythmia. As we learn in today's Moves in Medicine, not all ...

MONTREAL and CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...

CARMEL, Ind. — Ever since Addyson Czarnecki first jumped in at eight years old, the pool has been her happy place. "I really love the feeling of when your body is so tired that your lungs are burning, ...

RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...

AVNRT commonly affects young, healthy women without structural heart disease. 5 Common tachycardic risk factors include drug induction, caffeine, prior history of heart disease, alcohol use, stress, ...